This report describes the development of an assay system which overcomes the difficulty of detecting immune responses of patients with Trichomonas vaginitis by making use of peripheral blood leukocytes obtained from such patients. When peripheral blood leukocytes from the patient were stimulated in microcultures with the soluble antigen extracted from Trichomonas vaginalis, significant degrees of proliferation ensued, as measured by the incorporation of [methyl- 3H]thymidine 4 to 5 days after initiation. The antigen-induced proliferation response of peripheral blood leukocytes is specific for T. vaginalis antigen. The T. vaginalis-specific [methyl-3H]thymidine incorporation is mediated by Leu-1-positive cells, namely, T lymphocytes, in the peripheral blood leukocyte population. This assay system should prove useful for the analysis of the immune response to the protozoa in patients with Trichomonas vaginitis.
Trichomonas vaginitis is generally believed to be caused by Trichomonas vaginalis. It is often observed, however, that some patients complain of severe itching or irritation in the genital region but seem to have no symptoms other than the genital di$charge (1, 5, 7, 10) . The real etiology of Trichomonas vaginitis still remains to be analyzed. To examine the antigenicity of T. vaginalis, the soluble antigen was extracted from protozoa cultured in vitro. The soluble antigen has been shown to elicit an anti-Trichomonas antibody in mice (13) . Although patients with Trichomonas vaginitis raise a significant level of antibody specific to the antigen in a hemagglutination assay, the responsiveness of the antibody in patients is not so strong (unpublished data). The immunological study of Trichomonas vaginitis has been hampered by the lack of a reproducible assay system for the disease. An antigen-specific T-lymphocyte proliferation assay giving significant degrees of stimulation has been established in rabbits, guinea pigs, and mice (2, 8, 9) . In humans, proliferation responses of peripheral blood leukocytes (PBL) to various antigens (e.g., Toxoplasma antigen, etc.) have been reported (3, 11, 12 Antigens. The preparation method of the soluble extract from the in vitro-cultured T. vaginalis line (ATCC 3001) has been described previously (13) . Briefly, T. vaginalis cultured in the medium described above was extensively washed with 0.05 M phosphatebuffered saline (PBS) at 3,000 rpm for 15 min. After being washed five times, the protozoa were sonicated with a Sonicator (Tominaga Industry Co., Tokyo, Japan) for 60 s on ice, and the sonicated material was supercentrifuged at 10,000 rpm for 60 min. The supernatant was dialyzed in PBS for 3 
RESULTS
Response of PBL to T. vaginalis antigen. PBL from patients with Trichomonas vaginitis were found to be highly responsive to in vitro stimulation with T. vaginalis soluble antigen, as measured by incorporation of 3H-TdR (Fig. 1) . In 18 consecutive experiments in which PBL were collected from 10 patients with Trichomonas vaginitis and from 8 healthy controls, the mean of the response (/cpm) of 105 PBL from patients to 100 ,ug of the antigen per ml was 9,879 (the range of response was 20,510 to 940), whereas that of the PBL from healthy controls was 1,080 (the range of response was 2,800 to 0). Cultures from 7 of 10 infected patients had a positive stimulation ratio (mean, 5.1; range, 7.3 to 1.9), whereas no cultures from controls had a significant positive stimulation ratio (mean, 1.6; range, 2.6 to 0.9). Differences in the lymphocyte transformation response between infected patients and healthy controls were significant if expressed either as antigen-specific increase in cpm (Acpm) (P < 0.002) or as stimulation ratio (cpm obtained from cultures with antigen/cpm obtained from cultures without antigen) (P < 0.002). Thus, T. vaginalis-specific stimulation was only detectable with the PBL from patients with Trichomonas vaginitis. The significant responses (Acpm, >6,000; stimulation ratio, >4) can therefore be considered as indicative of T. vaginalis infection, although a negative response does not exclude the infection diagnosed by microscopic examination. The negative response of some patients is discussed later.
The details of the responses of PBL from either patients or controls to in vitro challenge with the T. vaginalis antigen are shown in Fig. 2 and (Fig. 2) ; larger cell numbers showed either a plateau or a decrease in 3H-TdR incorporation by the antigen-stimulated cultures and often a continued rise in 3H-TdR incorporation by the control cultures. The kinetics of the antigen response are shown in Fig. 2 . In general, the response peaked at 5 days, but occasionally the peak was reached at 6 days (105 PBL, in this particular experiment). The data presented in Fig. 1 T-cell dependence of T. vaginalis antigen-induced proliferation. The T-cell dependence of the antigen-induced proliferation response of the PBL from the patients was demonstrated by pretreating the population with anti-Leu-1 antibody plus complement ( Table 2 ). The response of the PBL from a patient with Trichomonas vaginitis to both the soluble extract of T. vaginalis and PPD was almost completely eliminated by this treatment at T. vaginalis antigen concentrations of 100 and 10 p.g/ml. The response of the PBL from a healthy control to PPD was also eliminated by the same pretreatment; in contrast, the PBL did not show significant incorporation of 3H-TdR with the Trichomonas antigen. This experiment demonstrated that T. vaginalisinduced proliferation responses of PBL are mainly mediated by Leu-1-positive cells, or T cells, in the PBL population.
Fractionation of crude Trichomonas antigen by Sephadex chromatography. To purify the antigenic molecules from the crude antigen, we chromatographed the soluble Trichomonas antigen on Sephadex G-200; eluted column fractions were tested for their capacity to stimulate the 3H-TdR incorporation of PBL from patients with Trichomonas vaginitis. The elution pattern detected with optical density is depicted in Fig. 3 . Two main peaks (molecular weights, 160,000 and 12,500) and three small peaks (molecular weights, 100,000, 74,000, and 34,000) were eluted and fractionated into five fractions. These fractions were assayed for ability to stimulate 3H-TdR incorporation of PBL. Fractions II, III, and IV appeared to be potent antigens to the proliferation response of PBL (Table 3) . Typical 3H-TdR incorporation patterns of PBL are listed in Table 3 . PBL from patient no. 1 were stimulated by both fractions II and IV (fraction II, 10,460 cpm; fraction IV, 8,780 cpm). PBL from patient no. 2 were stimulated by fractions II and III, whereas only fraction II could stimulate PBL from patient no. 3. Thus, fraction II was found to be the most potent antigen for the proliferation response of PBL in each case, although fractions III and IV could stimulate PBL to uptake 3H-TdR in certain cases. The time of maximum response did not shift with the various concentrations of the fractioned antigens over a 100-fold range (data not shown).
DISCUSSION
The data presented in this study clearly demonstrate that Trichomonas antigen-specific proliferation responses can be observed in PBL from Trichomonas vaginitis patients. The 3H-TdR incorporation of PBL was eliminated by treatment with monoclonal anti-Leu-1 antibody plus complement. Anti-Leu-1 antibody is specific for the common determinant on human T cells. Thus, this assay system should prove useful for the analysis of immune responses, 
